Skip to main content

Tabuteau Herriot's Form 4 filing

Axsome Therapeutics, Inc. (AXSM) · filed Jun 9, 2026

Accession no.
0001193125-26-264038
Filed
Jun 9, 2026
Trade date
Jun 9, 2026
Filing delay
Same day
Rule 10b5-1 plan
Checked

This filing lists 2 non-derivative transactions and 1 derivative transaction. Open-market sales total $12.0M. It was filed on the trade date.

Reporting owners

A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.

Reporting owners on this filing
OwnerRelationship to the company
Tabuteau HerriotCIK 0001219927Director, Officer (Chief Executive Officer), 10% Owner

Non-derivative securities (Table I)

Acquisitions and disposals of common stock and similar shares, one row per line on the filing.

Non-derivative transactions
Trade dateSecurityTransactionSharesPriceValueShares afterOwnershipFlags
Jun 9, 2026Common StockMOption exerciseAcquired+49,670$4.95+$245,866.556,899Direct
Jun 9, 2026Common StockSSaleDisposed−49,670$241.01F4−$11,970,966.77,229Direct

Derivative securities (Table II)

Options, warrants, restricted stock units and similar. Shares are the underlying shares; price and value are for the derivative itself, and the holding after is in derivative units.

Derivative transactions
Trade dateSecurityTransactionUnderlying sharesUnit priceValueHeld afterOwnershipFlags
Jun 9, 2026Common StockMOption exerciseDisposed−49,670$0.00$099,330Direct

Footnotes and remarks

Livermore keeps the footnotes that transaction prices refer to, all footnotes of amendments (Form 4/A) and the filing's remarks. Other footnotes, such as how indirect holdings are held or the details of a trading plan, are only in the original on SEC EDGAR.

F4

Represents the weighted average sale price of a series of open market transactions with sale prices ranging between $236.11 and $244.13.

Referenced by the price of 1 transaction in Table I.

Read the full filing on SEC EDGAR (opens in a new tab)